Saakshi Medtech and Panels Limited — Important, 13-11-2024: Financial Result Updates

**Saakshi Medtech and Panels Limited Financial Summary**

The company's total revenue for the half-year ended September 30, 2024, stands at ₹44.45 crore, a decrease of approximately 27.05% compared to the previous half-year's revenue of ₹61.29 crore. This decline could stem from reduced demand or market challenges affecting operational performance.

Net profit for the period is reported at ₹3.45 crore, down from ₹5.54 crore year-over-year, translating to an Earnings Per Share (EPS) of ₹1.96, compared to ₹3.14 previously. The profit decline indicates increased operational costs or lower sales volumes that may have impacted profitability.

Operational costs totaled ₹39.95 crore, reflecting a decrement of about 25.36% year-on-year. A significant contributor was the cost of raw materials, which decreased, aligning with lower production or inventory levels, while finance costs significantly declined, signaling improved cost management.

The balance sheet showcases total assets of ₹127.45 crore with current liabilities of ₹17.88 crore and non-current liabilities of ₹12.79 crore, indicating a stable financial position despite recent short-term pressures. The company retains sufficient cash reserves amounting to ₹10.21 crore for operational flexibility.

Looking forward, the strategic focus seems to revolve around enhancing cost efficiencies and exploring market opportunities to rebuild revenue. Given the current financial performance, investors may consider monitoring the stock closely, weighing potential recovery against ongoing industry challenges.